Lineage Cell Therapeutics
Lineage Cell Therapeutics develops allogeneic cell therapies, including OpRegen® for age-related macular degeneration and OPC1 for spinal cord injuries, using a proprietary platform to create specialized human cells.
Specifications
- LocationCalifornia, USA
- Content Platform
- Colors






